Frequency of rare and multi viral high-risk HPV types infection in cervical high grade squamous intraepithelial lesions in a non-native dominant middle eastern country: a polymerase chain reaction-based pilot study
- PMID: 29945637
- PMCID: PMC6020339
- DOI: 10.1186/s13000-018-0716-x
Frequency of rare and multi viral high-risk HPV types infection in cervical high grade squamous intraepithelial lesions in a non-native dominant middle eastern country: a polymerase chain reaction-based pilot study
Abstract
Background: The incidence of abnormal cervical smears in the United Arab Emirates (UAE) is 3.6%. Data regarding specific high-risk HPV (hrHPV) genotypes are insufficient. Identification of hrHPV subtypes is essential to allow formulating effective vaccination strategies.
Methods: A total of 75 archival cervical cone biopsies with HSIL or higher lesions (2012-2016) were retrieved from a tertiary hospital, including HSIL (n = 70), adenocarcinoma in-situ (n = 1) and squamous cell carcinoma (n = 4). Five tissue sections (10-μ-thick each) were cut and DNA extracted using the QIAamp DNA FFPE Tissue Kit. GenomeMeTM's GeneNavTM HPV One qPCR Kit was used for specific detection of HPV 16 and 18; and non-16/18 samples were typed by GenomeMeTM's GeneNavTM HPV Genotyping qPCR Kit.
Results: Median age was 34 years (range 19-58) with 70% UAE Nationals. hrHPV detected were 16, 18, 31, 33, 35, 39, 45, 51, 52, 58, 59, 66 & 68. hrHPV testing was negative in 12% of cases. Most common types were HPV 16 (49%), HPV 31 (20%) and HPV 18 (6.6%). hrHPV 16 and/or 18 represented 56% and rare subtypes 32%. Co-infection was present in 16%. Eight cases had two-viral subtype infections and 4 cases had 3 subtype infections. Multi-viral HPV infection was limited to hrHPV 16, 18, 31 & 33 subtypes.
Conclusions: Infection by non HPV 16/18 is fairly common. A higher than expected incidence of rare subtype (20% hrHPV31) and multi-viral hrHPV (16%) were detected. This finding stresses the importance of this pilot study as currently only quadravalent vaccine is offered to control the HPV infection in the UAE population.
Keywords: Cervical cancer; HPV; Papillomaviridae; UAE.
Conflict of interest statement
Ethics approval and consent to participate
The study was approved by Al Ain Medical District Human Research Ethics Committee. The project number is #15/117 2015-4243. Additional patient consent was not required by the ethics committee for this retrospective study.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.Clin Epigenetics. 2016 Sep 13;8(1):96. doi: 10.1186/s13148-016-0263-9. eCollection 2016. Clin Epigenetics. 2016. PMID: 27651839 Free PMC article.
-
Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.Diagn Cytopathol. 2017 May;45(5):384-390. doi: 10.1002/dc.23678. Epub 2017 Mar 1. Diagn Cytopathol. 2017. PMID: 28247516
-
Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.Int J Clin Oncol. 2016 Jun;21(3):580-7. doi: 10.1007/s10147-015-0929-x. Epub 2015 Nov 27. Int J Clin Oncol. 2016. PMID: 26614089
-
Aptima HPV messenger RNA testing and histopathologic follow-up in women with HSIL cytology: A study emphasizing additional review of HPV-negative cases.Cancer Cytopathol. 2021 Aug;129(8):622-631. doi: 10.1002/cncy.22421. Epub 2021 Mar 25. Cancer Cytopathol. 2021. PMID: 33764649 Review.
-
A meta-analysis of human papillomavirus prevalence and types among Iranian women with normal cervical cytology, premalignant lesions, and cervical cancer.J Med Virol. 2021 Aug;93(8):4647-4658. doi: 10.1002/jmv.26928. Epub 2021 Mar 26. J Med Virol. 2021. PMID: 33694179 Review.
Cited by
-
Human papillomavirus prevalence and genotypes in Gulf Cooperation Council countries: A scoping review 2017-2024.Qatar Med J. 2024 Jul 31;2024(3):33. doi: 10.5339/qmj.2024.33. eCollection 2024. Qatar Med J. 2024. PMID: 39131793 Free PMC article.
-
Reasons for non-attendance to cervical cancer screening and acceptability of HPV self-sampling among Bruneian women: A cross-sectional study.PLoS One. 2022 Mar 14;17(3):e0262213. doi: 10.1371/journal.pone.0262213. eCollection 2022. PLoS One. 2022. PMID: 35287163 Free PMC article.
-
Lower Prevalence of Human Papillomavirus in Head and Neck Squamous Cell Carcinoma in Middle Eastern Population: Clinical Implications for Diagnosis and Prevention.Cureus. 2023 Feb 13;15(2):e34912. doi: 10.7759/cureus.34912. eCollection 2023 Feb. Cureus. 2023. PMID: 36938175 Free PMC article.
-
Co-prevalence of human Papillomaviruses (HPV) and Epstein-Barr virus (EBV) in healthy blood donors from diverse nationalities in Qatar.Cancer Cell Int. 2020 Apr 3;20:107. doi: 10.1186/s12935-020-01190-2. eCollection 2020. Cancer Cell Int. 2020. PMID: 32265596 Free PMC article.
-
Human Papillomaviruses-Related Cancers: An Update on the Presence and Prevention Strategies in the Middle East and North African Regions.Pathogens. 2022 Nov 19;11(11):1380. doi: 10.3390/pathogens11111380. Pathogens. 2022. PMID: 36422631 Free PMC article. Review.
References
-
- Health statistics 2015- Health Authority Abu Dhabi. Available from: https://www.haad.ae/HAAD/LinkClick.aspx?fileticket=gzx_WUkD27Y%3d&tabid=.... Accessed 28 Aug 2017
-
- International Agency of Research on Cancer, GLOBOCAN. Incidence and mortality data for the United Arab Emirates. 2008. Available from: http://globocan.iarc.fr/. Accessed 28 Aug 2017
-
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC monographs 90-7: Studies of Cancer in Humans. Available from http://monographs.iarc.fr/ENG/Monographs/vol90/mono90-7.pdf. Accessed 25 Dec 2017
-
- Stoler M, et al. Tumours of the uterine cervix. In: Kurman R, Carcangiu ML, Heerington CM, Young RH, et al., editors. WHO Classification of Tumours of Female Reproductive Organs. 4. Lyon: International Agency for Reseach on Cancer; 2014. pp. 189–206.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials